Inspire Pharmaceuticals, a biopharmaceutical company, has appointed Alan Holmer to its board of directors.
Subscribe to our email newsletter
Mr Holmer previously served for two years on Inspire’s board, resigning in February 2007 to accept an appointment in the US Treasury Department.
Mr Holmer has received an AB degree from Princeton University and a JD from Georgetown University.
Kenneth Lee, Jr, chairman of Inspire, said: “We are pleased to have Alan rejoin Inspire’s board of directors. Alan has broad knowledge of the pharmaceutical industry and global markets, which will be particularly valuable in the current challenging economic environment.
“Most importantly, we appreciate Alan’s understanding of Inspire’s business opportunities and his passion for providing patients with innovative therapeutic treatments.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.